Free shipping on all orders over $ 500

Mavorixafor trihydrochloride

Cat. No. M13939

All AbMole products are for research use only, cannot be used for human consumption.

Mavorixafor trihydrochloride Structure
Synonym:

AMD-070 trihydrochloride

Size Price Availability
5mg USD 168  USD168 1-2 Weeks
10mg USD 300  USD300 1-2 Weeks
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Mavorixafor trihydrochloride (AMD-070 trihydrochloride) is a potent, selective and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 and 9 nM, respectively.

Chemical Information
Molecular Weight 458.86
CAS Number 2309699-17-8
Solubility (25°C) DMSO 100 mg/mL
Water 90 mg/mL
Storage 2-8°C, dry, sealed
Related CXCR Products
Elubrixin

Elubrixin (SB-656933) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

VUF 11222 

VUF 11222 is a CXCR3 non-peptide-like agonist.

(±)-AMG 487 

(±)-AMG 487 is a racemate of AMG 487.

Elubrixin tosylate

Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

Elubrixin hydrochloride

Elubrixin (SB-656933) hydrochloride is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mavorixafor trihydrochloride, AMD-070 trihydrochloride supplier, CXCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.